Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where James P. Beck is active.

Publication


Featured researches published by James P. Beck.


Bioorganic & Medicinal Chemistry Letters | 1999

Thiazolo[4,5-d]pyrimidine thiones and -ones as corticotropin-releasing hormone (CRH-R1) receptor antagonists.

James P. Beck; Matt A. Curry; Robert J. Chorvat; Larry W. Fitzgerald; Paul J. Gilligan; Robert Zaczek; George L. Trainor

A series of thiazolo[4,5-d]pyrimidine thiones and -ones was prepared and discovered to have good binding affinity to the CRH-R1 receptor, thus showing promise as a new class of potential anxiolytics and/or antidepressants.


Bioorganic & Medicinal Chemistry Letters | 1999

Purin-8-ones as corticotropin-releasing hormone (CRH-R1) receptor antagonists

James P. Beck; Argyrios G. Arvanitis; Matt A. Curry; Joseph T. Rescinito; Larry W. Fitzgerald; Paul J. Gilligan; Robert Zaczek; George L. Trainor

A series of purin-8-ones was prepared and discovered to have excellent binding affinity to the CRH-R1 receptor. Structure-activity studies focused on amine side-chain optimization, urea substitution and pyridyl isostere incorporation. Thus, the highly potent purin-8-ones show promise as a new class of potential anxiolytics and/or antidepressants.


Journal of Medicinal Chemistry | 2003

Human β-Secretase (BACE) and BACE Inhibitors

Varghese John; James P. Beck; Michael J. Bienkowski; Sukanto Sinha; Robert L. Heinrikson


Archive | 2002

N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives

Varghese John; Michel Maillard; Barbara Jagodzinska; James P. Beck; Andrea Gailunas; John Freskos; John Mickelson; Lakshman Samala; Jennifer Sealy; Ruth E. Tenbrink; Lawrence Fang


Archive | 2002

Macrocycles useful in the treatment of alzheimer's disease

Shon R. Pulley; James P. Beck; Ruth E. Tenbrink; Jon S. Jacobs


Journal of Medicinal Chemistry | 1999

Non-Peptide Corticotropin-Releasing Hormone Antagonists: Syntheses and Structure−Activity Relationships of 2-Anilinopyrimidines and -triazines

Argyrios G. Arvanitis; Paul J. Gilligan; Robert J. Chorvat; Robert Scott Cheeseman; Thomas E. Christos; Rajagopal Bakthavatchalam; James P. Beck; Anthony J. Cocuzza; Frank W. Hobbs; Richard Gerald Wilde; Charles R. Arnold; Dennis R. Chidester; Matthew A. Curry; Liqi He; Andrea Hollis; John D. Klaczkiewicz; Paul Krenitsky; Joseph P. Rescinito; Everett Latham Scholfield; Steven Culp; Errol B. De Souza; Lawrence W. Fitzgerald; Dimitri E. Grigoriadis; S. William Tam; Y.Nancy Wong; Shiew-Mei Huang,✗,◊ and; Helen L. Shen


Journal of Medicinal Chemistry | 1999

Synthesis, Corticotropin-Releasing Factor Receptor Binding Affinity, and Pharmacokinetic Properties of Triazolo-, Imidazo-, and Pyrrolopyrimidines and -pyridines

Robert J. Chorvat; Rajagopal Bakthavatchalam; James P. Beck; Paul J. Gilligan; Richard Gerald Wilde; Anthony J. Cocuzza; Frank W. Hobbs; Robert Scott Cheeseman; Matthew A. Curry; Joseph P. Rescinito; Paul Krenitsky; Dennis R. Chidester; Yarem Ja; John D. Klaczkiewicz; Hodge Cn; Aldrich Pe; Wasserman Zr; Fernandez Ch; Zaczek R; Lawrence W. Fitzgerald; Huang Sm; Shen Hl; Wong Yn; Chien Bm; Argyrios G. Arvanitis


Archive | 1998

Aryl- and arylamino- substituted heterocycles as corticotropin releasing hormone antagonists

Anthony J. Cocuzza; Frank W. Hobbs; James P. Beck; Paul J. Gilligan


Archive | 1999

THIAZOLO 4,5-d]PYRIMIDINES AND PYRIDINES AS CORTICOTROPIN RELEASING FACTOR (CRF) ANTAGONISTS

James P. Beck


Archive | 1998

NITROGEN SUBSTITUTED IMIDAZO 4,5-c]PYRAZOLES AS CORTICOTROPIN RELEASING HORMONE ANTAGONISTS

James P. Beck; Paul J. Gilligan

Collaboration


Dive into the James P. Beck's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Barbara Jagodzinska

Buck Institute for Research on Aging

View shared research outputs
Top Co-Authors

Avatar

Michel Maillard

Institut de Chimie des Substances Naturelles

View shared research outputs
Researchain Logo
Decentralizing Knowledge